<DOC>
	<DOCNO>NCT00476437</DOCNO>
	<brief_summary>This trial conduct Japan . The purpose trial investigate safety effect biphasic insulin aspart 50 compare biphasic human insulin 50 patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>Safety Effect Biphasic Insulin Aspart 50 Patients With Type 2 Diabetes Mellitus .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type 2 diabetes mellitus Current treatment premixed human insulin preparation biphasic/premixed insulin analogue twice daily treatment least 8 week . HbA1C : le 11.0 % BMI : less 30.0 kg/m2 Total daily insulin dose : 100 IU/U Treatment oral hypoglycaemic agent within last 4 week . Treatment insulin sensitizer within last 12 week A lifestyle consider unsuitable trial ( frequent routine night shift worker etc . )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>